Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Epithelial Ovarian Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00003107
What this trial is testing

Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+8 more
Indiana University
Testing effectiveness (Phase 2)Study completedNCT02797964
What this trial is testing

A Phase 1/2 Trial of SRA737 in Subjects With Advanced Cancer

Who this might be right for
Advanced Solid Tumors or Non-Hodgkin's Lymphoma (NHL)
Sierra Oncology LLC - a GSK company 107
Early research (Phase 1)Study completedNCT05567601
What this trial is testing

Doxil/Caelyx BE Study

Who this might be right for
Ovarian CancerAIDS-related Kaposi SarcomaMultiple Myeloma+1 more
Baxter Healthcare Corporation 36
Early research (Phase 1)Study completedNCT00770536
What this trial is testing

AMG386 Comb w. Either Pegylated Liposomal Doxorubicin or Topotecan Subjects w. Advanced Recurrent Epithelial Ovarian CR

Who this might be right for
CancerCarcinomaFallopian Tube Cancer+6 more
Amgen 103
Testing effectiveness (Phase 2)Looking for participantsNCT07340164
What this trial is testing

Trastzumab Deruxtecan Versus SOC in Recurrent Ovarian That Progressed on Prior PARP Inhibitor Therapy

Who this might be right for
Ovarian CancerOvarian Carcinoma, RecurrentOvarian Cancer Metastatic Recurrent+1 more
Yonsei University 116
Testing effectiveness (Phase 2)Looking for participantsNCT07171528
What this trial is testing

Secondary Cytoreductive Surgery After Chemotherapy for Recurrent Epithelial Ovarian Cancer

Who this might be right for
Ovarian Cancer
National Cancer Center, Korea 80
Early research (Phase 1)Study completedNCT00020267
What this trial is testing

Vaccine Therapy in Treating Patients With Metastatic Cancer

Who this might be right for
Lung CancerAdult Soft Tissue SarcomaColorectal Cancer+8 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Looking for participantsNCT06769152
What this trial is testing

A Phase II Clinical Study to Evaluate the Efficacy and Safety of HLX43 (Anti-PD-L1 ADC) in Patients With Advanced Gynecological Malignant Tumors

Who this might be right for
Cervical CancerOvarian Cancer
Shanghai Henlius Biotech 190
Testing effectiveness (Phase 2)Study completedNCT01435122
What this trial is testing

Axitinib in Advanced Carcinoid Tumors

Who this might be right for
Carcinoid Tumor
H. Lee Moffitt Cancer Center and Research Institute 30
Testing effectiveness (Phase 2)Looking for participantsNCT07410494
What this trial is testing

Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors

Who this might be right for
CancerBreast CancerNon-Small Cell Lung Cancer (NSCLC)+10 more
Essen Biotech 85
Early research (Phase 1)Study completedNCT00049296
What this trial is testing

Thalidomide and Docetaxel in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Case Comprehensive Cancer Center 26
Early research (Phase 1)WithdrawnNCT06681870
What this trial is testing

ASP1893 in Adults With Advanced CLDN6-positive Solid Tumors

Who this might be right for
CLDN6-positive Solid TumorOvarian CancerEndometrial Cancer+3 more
Astellas Pharma Global Development, Inc.
Not applicableLooking for participantsNCT07451483
What this trial is testing

Ventral Hernias Following Cytoreductive Surgery : Incidence, Risk Factors and Surgical Management.

Who this might be right for
Ventral HerniasCytoreductive Surgery
Jules Bordet Institute 500
Early research (Phase 1)Ended earlyNCT04315233
What this trial is testing

Ribociclib&Belinostat In Patients w Metastatic Triple Neg Breast Cancer & Recurrent Ovarian Cancer w Response Prediction By Genomics

Who this might be right for
Metastatic Breast CancerRecurrent Ovarian Carcinoma
University of Utah 12
Early research (Phase 1)Study completedNCT01155258
What this trial is testing

Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors

Who this might be right for
Extensive Stage Small Cell Lung CancerHereditary ParagangliomaMale Breast Cancer+45 more
University of Southern California 19
Large-scale testing (Phase 3)UnknownNCT01087268
What this trial is testing

Hyperbaric Oxygen Therapy in Treating Long-Term Gastrointestinal Adverse Effects Caused by Radiation Therapy in Patients With Pelvic Cancer

Who this might be right for
Bladder CancerCervical CancerColorectal Cancer+9 more
Royal Marsden NHS Foundation Trust 75
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07295132
What this trial is testing

RESCUE Study (REcurrent Ovarian Cancer Secondary Cytoreduction Using Chemotherapy rEsponse)

Who this might be right for
Ovarian Cancer RecurrentPlatinum Sensitive Ovarian Cancer
Asan Medical Center 160
Not applicableEnded earlyNCT00904514
What this trial is testing

Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical Trial

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 241
Testing effectiveness (Phase 2)Study completedNCT03287674
What this trial is testing

TIL Therapy in Combination With Checkpoint Inhibitors for Metastatic Ovarian Cancer

Who this might be right for
Metastatic Ovarian Cancer
Inge Marie Svane 7
Early research (Phase 1)Active Not RecruitingNCT04044859
What this trial is testing

ADP-A2M4CD8 as Monotherapy or in Combination With Either Nivolumab or Pembrolizumab in HLA-A2+ Subjects With MAGE-A4 Positive Tumors (SURPASS)

Who this might be right for
Endometrial CancerEsophageal CancerEsophagogastric Junction (EGJ)+6 more
USWM CT, LLC 120
Next Page